Valar Labs develops AI diagnostics that interpret solid tumors, enabling physicians and patients to make evidence-based treatment decisions. Their proprietary technology focuses on the tumor microenvironment to provide insights into therapeutic responses. The company aims to reduce uncertainty in cancer treatment selection for oncologists and patients.